Peer Review reports
From: LncRNA WEE2-AS1 is a diagnostic biomarker that predicts poor prognoses in patients with glioma
| Original Submission | ||
|---|---|---|
| 18 May 2022 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| 13 Aug 2022 | Reviewed | Reviewer Report |
| 19 Aug 2022 | Reviewed | Reviewer Report |
| 24 Aug 2022 | Reviewed | Reviewer Report |
| 30 Sep 2022 | Author responded | Author comments - Dongming Yan |
| Resubmission - Version 3 | ||
| 30 Sep 2022 | Submitted | Manuscript version 3 |
| 11 Oct 2022 | Author responded | Author comments - Dongming Yan |
| Resubmission - Version 4 | ||
| 11 Oct 2022 | Submitted | Manuscript version 4 |
| 4 Nov 2022 | Reviewed | Reviewer Report |
| 6 Nov 2022 | Reviewed | Reviewer Report |
| 10 Dec 2022 | Author responded | Author comments - Dongming Yan |
| Resubmission - Version 5 | ||
| 10 Dec 2022 | Submitted | Manuscript version 5 |
| 14 Dec 2022 | Author responded | Author comments - Dongming Yan |
| Resubmission - Version 6 | ||
| 14 Dec 2022 | Submitted | Manuscript version 6 |
| 10 Jan 2023 | Reviewed | Reviewer Report |
| 12 Jan 2023 | Reviewed | Reviewer Report |
| Resubmission - Version 7 | ||
| Submitted | Manuscript version 7 | |
| Publishing | ||
| 31 Jan 2023 | Editorially accepted | |
| 6 Feb 2023 | Article published | 10.1186/s12885-023-10594-y |
You can find further information about peer review here.